{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:13:15Z","timestamp":1768295595620,"version":"3.49.0"},"reference-count":54,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A safe, effective, and inclusive gene therapy will significantly benefit a large population of patients with hemophilia. We used a minimally invasive transcutaneous ultrasound-mediated gene delivery (UMGD) strategy combined with microbubbles (MBs) to enhance gene transfer into 4 canine livers. A mixture of high-expressing, liver-specific human factor VIII (hFVIII) plasmid and MBs was injected into the hepatic vein via balloon catheter under fluoroscopy guidance with simultaneous transcutaneous UMGD treatment targeting a specific liver lobe. Therapeutic levels of hFVIII expression were achieved in all 4 dogs, and hFVIII levels were maintained at a detectable level in 3 dogs throughout the 60-day experimental period. Plasmid copy numbers correlated with hFVIII antigen levels, and plasmid-derived messenger RNA (mRNA) was detected in treated livers. Liver transaminase levels and histology analysis indicated minimal liver damage and a rapid recovery after treatment. These results indicate that liver-targeted transcutaneous UMGD is promising as a clinically feasible therapy for hemophilia A and other diseases.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021006016","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T19:17:02Z","timestamp":1650050222000},"page":"3557-3568","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Transcutaneous ultrasound-mediated gene delivery into canine livers achieves therapeutic levels of factor VIII\u00a0expression"],"prefix":"10.1182","volume":"6","author":[{"given":"Megan A.","family":"Manson","sequence":"first","affiliation":[{"name":"1Center for Immunity and Immunotherapies, Seattle Children\u2019s Research Institute, Seattle, WA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5559-8562","authenticated-orcid":false,"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[{"name":"2Department of Radiology, University of Washington, Seattle, WA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8975-6730","authenticated-orcid":false,"given":"Alexander","family":"Novokhodko","sequence":"additional","affiliation":[{"name":"1Center for Immunity and Immunotherapies, Seattle Children\u2019s Research Institute, Seattle, WA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7199-3271","authenticated-orcid":false,"given":"Chun-Yu","family":"Chen","sequence":"additional","affiliation":[{"name":"1Center for Immunity and Immunotherapies, Seattle Children\u2019s Research Institute, Seattle, WA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Parker","sequence":"additional","affiliation":[{"name":"3Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3305-0261","authenticated-orcid":false,"given":"Keith R.","family":"Loeb","sequence":"additional","affiliation":[{"name":"3Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; and"},{"name":"4Department of Pathology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9377-1354","authenticated-orcid":false,"given":"Masaki","family":"Kajimoto","sequence":"additional","affiliation":[{"name":"1Center for Immunity and Immunotherapies, Seattle Children\u2019s Research Institute, Seattle, WA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carley","family":"Campbell","sequence":"additional","affiliation":[{"name":"1Center for Immunity and Immunotherapies, Seattle Children\u2019s Research Institute, Seattle, WA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9343-4099","authenticated-orcid":false,"given":"Rainer F.","family":"Storb","sequence":"additional","affiliation":[{"name":"3Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; and"},{"name":"5Department of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6520-2373","authenticated-orcid":false,"given":"Carol H.","family":"Miao","sequence":"additional","affiliation":[{"name":"1Center for Immunity and Immunotherapies, Seattle Children\u2019s Research Institute, Seattle, WA;"},{"name":"6Department of Pediatrics, University of Washington, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2022,6,17]]},"reference":[{"issue":"8","key":"2022061715231922300_B1","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1021\/mp300037t","article-title":"Efficient microbubble- and ultrasound-mediated plasmid DNA delivery into a specific rat liver lobe via a targeted injection and acoustic exposure using a novel ultrasound system","volume":"9","author":"Song","year":"2012","journal-title":"Mol Pharm."},{"issue":"9","key":"2022061715231922300_B2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/mt.2013.107","article-title":"Ultrasound-targeted microbubble destruction-mediated gene delivery into canine livers","volume":"21","author":"Noble","year":"2013","journal-title":"Mol Ther."},{"key":"2022061715231922300_B3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2018.04.012","article-title":"Prolonging pulse duration in ultrasound-mediated gene delivery lowers acoustic pressure threshold for efficient gene transfer to cells and small animals","volume":"279","author":"Tran","year":"2018","journal-title":"J Control Release."},{"issue":"8","key":"2022061715231922300_B4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.7326\/M19-1208","article-title":"Establishing the prevalence and prevalence at birth of hemophilia in males: a meta-analytic approach using national registries","volume":"171","author":"Iorio","year":"2019","journal-title":"Ann Intern Med."},{"issue":"13","key":"2022061715231922300_B5","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.21037\/atm-21-747","article-title":"Current therapeutic approaches in the management of hemophilia \u2013 a consensus view by the Romanian Society of Hematology","volume":"9","author":"Hotea","year":"2021","journal-title":"Ann Transl Med."},{"issue":"6","key":"2022061715231922300_B6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/hae.14412","article-title":"Prophylaxis in children with haemophilia in an evolving treatment landscape","volume":"27","author":"Mancuso","year":"2021","journal-title":"Haemophilia."},{"key":"2022061715231922300_B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia."},{"issue":"3","key":"2022061715231922300_B8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3324\/haematol.2019.232132","article-title":"Hemophilia therapy: the future has begun","volume":"105","author":"Mannucci","year":"2020","journal-title":"Haematologica."},{"issue":"23","key":"2022061715231922300_B9","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM200106073442307","article-title":"The hemophilias \u2013 from royal genes to gene therapy","volume":"344","author":"Mannucci","year":"2001","journal-title":"N Engl J Med."},{"issue":"4","key":"2022061715231922300_B10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.blre.2013.06.002","article-title":"Hemophilia A in the third millennium","volume":"27","author":"Franchini","year":"2013","journal-title":"Blood Rev."},{"key":"2022061715231922300_B11","first-page":"221","article-title":"Recent advances in the treatment of hemophilia: a review","volume":"15","author":"Marchesini","year":"2021","journal-title":"Biologics."},{"issue":"1","key":"2022061715231922300_B12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/hae.14205","article-title":"Long-term safety and efficacy of emicizumab for up to 5.8 years and patients\u2019 perceptions of symptoms and daily life: a phase 1\/2 study in patients with severe haemophilia A","volume":"27","author":"Shima","year":"2021","journal-title":"Haemophilia."},{"key":"2022061715231922300_B13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.omtm.2019.07.005","article-title":"Transcutaneous ultrasound-mediated nonviral gene delivery to the liver in a porcine model","volume":"14","author":"Tran","year":"2019","journal-title":"Mol Ther Methods Clin Dev."},{"key":"2022061715231922300_B14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.omtm.2018.06.008","article-title":"Ultrasound-mediated gene therapy in swine livers using single-element, multi-lensed, high-intensity ultrasound transducers","volume":"10","author":"Noble-Vranish","year":"2018","journal-title":"Mol Ther Methods Clin Dev."},{"key":"2022061715231922300_B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbiomolbio.2018.07.012","article-title":"Advances in mechanism studies on ultrasonic gene delivery at cellular level","volume":"142","author":"Yu","year":"2019","journal-title":"Prog Biophys Mol Biol."},{"key":"2022061715231922300_B16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jconrel.2020.06.008","article-title":"Ultrasound and microbubble mediated therapeutic delivery: underlying mechanisms and future outlook","volume":"326","author":"Chowdhury","year":"2020","journal-title":"J Control Release."},{"issue":"6","key":"2022061715231922300_B17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.gt.3302925","article-title":"Gene therapy progress and prospects: ultrasound for gene transfer","volume":"14","author":"Newman","year":"2007","journal-title":"Gene Ther."},{"issue":"2","key":"2022061715231922300_B18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.gendis.2016.08.001","article-title":"Ultrasound-targeted microbubble destruction in gene therapy: a new tool to cure human diseases","volume":"4","author":"Wu","year":"2016","journal-title":"Genes Dis."},{"issue":"4","key":"2022061715231922300_B19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5662\/wjm.v3.i4.39","article-title":"Sonoporation: gene transfer using ultrasound","volume":"3","author":"Tomizawa","year":"2013","journal-title":"World J Methodol."},{"issue":"7","key":"2022061715231922300_B20","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.ymthe.2018.04.020","article-title":"Ultrasound-mediated gene delivery enhances tendon allograft integration in mini-pig ligament reconstruction","volume":"26","author":"Bez","year":"2018","journal-title":"Mol Ther."},{"issue":"7","key":"2022061715231922300_B21","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1177\/0271678X17753514","article-title":"Feedback control of microbubble cavitation for ultrasound-mediated blood-brain barrier disruption in non-human primates under magnetic resonance guidance","volume":"39","author":"Kamimura","year":"2019","journal-title":"J Cereb Blood Flow Metab."},{"issue":"11","key":"2022061715231922300_B22","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.7150\/thno.24911","article-title":"Three-dimensional transcranial microbubble imaging for guiding volumetric ultrasound-mediated blood-brain barrier opening","volume":"8","author":"Jones","year":"2018","journal-title":"Theranostics."},{"key":"2022061715231922300_B23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jconrel.2017.07.004","article-title":"Ultrasound targeted CNS gene delivery for Parkinson\u2019s disease treatment","volume":"261","author":"Fan","year":"2017","journal-title":"J Control Release."},{"issue":"16","key":"2022061715231922300_B24","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.7150\/thno.26869","article-title":"State-of-the-art of microbubble-assisted blood-brain barrier disruption","volume":"8","author":"Song","year":"2018","journal-title":"Theranostics."},{"key":"2022061715231922300_B25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0065-2660(05)54007-0","article-title":"A novel gene expression system: non-viral gene transfer for hemophilia as model systems","volume":"54","author":"Miao","year":"2005","journal-title":"Adv Genet."},{"key":"2022061715231922300_B26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.omtm.2020.10.013","article-title":"Minimal essential human factor VIII alterations enhance secretion and gene therapy efficiency","volume":"19","author":"Cao","year":"2020","journal-title":"Mol Ther Methods Clin Dev."},{"key":"2022061715231922300_B27","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.omtn.2022.01.006","article-title":"Ultrasound-mediated gene delivery of factor VIII plasmids for hemophilia A gene therapy in mice","volume":"27","author":"Song","year":"2022","journal-title":"Mol Ther Nucleic Acids."},{"issue":"22","key":"2022061715231922300_B28","first-page":"5722","article-title":"Enhancing therapeutic efficacy of in\u00a0vivo platelet-targeted gene therapy in hemophilia A mice","volume":"4","author":"Wang","year":"2020","journal-title":"Blood Adv."},{"key":"2022061715231922300_B29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jconrel.2014.03.002","article-title":"Development of therapeutic microbubbles for enhancing ultrasound-mediated gene delivery","volume":"182","author":"Sun","year":"2014","journal-title":"J Control Release."},{"issue":"8","key":"2022061715231922300_B30","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/mt.2011.61","article-title":"In vivo expansion of regulatory T cells with IL-2\/IL-2 mAb complexes prevents anti-factor VIII immune responses in hemophilia A mice treated with factor VIII plasmid-mediated gene therapy","volume":"19","author":"Liu","year":"2011","journal-title":"Mol Ther."},{"issue":"20","key":"2022061715231922300_B31","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1182\/blood-2009-05-217315","article-title":"Anti-CD3 antibodies modulate anti-factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy","volume":"114","author":"Peng","year":"2009","journal-title":"Blood."},{"issue":"11","key":"2022061715231922300_B32","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1182\/blood.V87.11.4671.bloodjournal87114671","article-title":"Sustained expression of therapeutic levels of human factor VIII in mice","volume":"87","author":"Connelly","year":"1996","journal-title":"Blood."},{"key":"2022061715231922300_B33","author":"Lyle"},{"key":"2022061715231922300_B34","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S1525-0016(16)34436-7","article-title":"Ultrasound and microbubbles mediated factor VIII plasmid gene therapy in hemophilia A mice [abstract]","volume":"21","author":"Song","year":"2013","journal-title":"Mol Ther."},{"issue":"6","key":"2022061715231922300_B35","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1006\/mthe.2001.0333","article-title":"Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in\u00a0vivo","volume":"3","author":"Miao","year":"2001","journal-title":"Mol Ther."},{"issue":"5","key":"2022061715231922300_B36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood-2018-07-820720","article-title":"Update on clinical gene therapy for hemophilia","volume":"133","author":"Perrin","year":"2019","journal-title":"Blood."},{"key":"2022061715231922300_B37","doi-asserted-by":"crossref","first-page":"100759","DOI":"10.1016\/j.blre.2020.100759","article-title":"Discussing investigational AAV gene therapy with hemophilia patients: a guide","volume":"47","author":"Sidonio","year":"2021","journal-title":"Blood Rev."},{"issue":"1","key":"2022061715231922300_B38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa1908490","article-title":"Multiyear follow-up of AAV5-hFVIII-SQ gene therapy for hemophilia A","volume":"382","author":"Pasi","year":"2020","journal-title":"N Engl J Med."},{"issue":"26","key":"2022061715231922300_B39","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1182\/bloodadvances.2017009878","article-title":"Hemophilia gene therapy comes of age","volume":"1","author":"George","year":"2017","journal-title":"Blood Adv."},{"issue":"2","key":"2022061715231922300_B40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/hae.13673","article-title":"The 1st WFH Gene Therapy Round Table: Understanding the landscape and challenges of gene therapy for haemophilia around the world","volume":"25","author":"Pierce","year":"2019","journal-title":"Haemophilia."},{"key":"2022061715231922300_B41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.omtm.2019.05.014","article-title":"Prevalence of anti-adeno-associated virus immune responses in international cohorts of healthy donors","volume":"14","author":"Kruzik","year":"2019","journal-title":"Mol Ther Methods Clin Dev."},{"issue":"2","key":"2022061715231922300_B42","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI79213","article-title":"Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy","volume":"125","author":"Chandler","year":"2015","journal-title":"J Clin Invest."},{"issue":"4","key":"2022061715231922300_B43","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1182\/blood-2008-10-181479","article-title":"Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy","volume":"113","author":"Niemeyer","year":"2009","journal-title":"Blood."},{"issue":"1","key":"2022061715231922300_B44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ng0598-13","article-title":"The kinetics of rAAV integration in the liver","volume":"19","author":"Miao","year":"1998","journal-title":"Nat Genet."},{"issue":"1","key":"2022061715231922300_B45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41587-020-0741-7","article-title":"A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells","volume":"39","author":"Nguyen","year":"2021","journal-title":"Nat Biotechnol."},{"issue":"11","key":"2022061715231922300_B46","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.3390\/jcm10112471","article-title":"Emerging immunogenicity and genotoxicity considerations of adeno-associated virus vector gene therapy for hemophilia","volume":"10","author":"Monahan","year":"2021","journal-title":"J Clin Med."},{"key":"2022061715231922300_B47","first-page":"213","article-title":"Non-Viral Gene Therapy","author":"Miao","year":"2011"},{"issue":"9","key":"2022061715231922300_B48","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/mds.27675","article-title":"Parkinson\u2019s disease gene therapy: will focused ultrasound and nanovectors be the next frontier?","volume":"34","author":"Price","year":"2019","journal-title":"Mov Disord."},{"issue":"1","key":"2022061715231922300_B49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1476-7120-11-11","article-title":"Gene therapy for cardiovascular disease mediated by ultrasound and microbubbles","volume":"11","author":"Chen","year":"2013","journal-title":"Cardiovasc Ultrasound."},{"key":"2022061715231922300_B50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jconrel.2015.08.059","article-title":"Drug and gene delivery across the blood-brain barrier with focused ultrasound","volume":"219","author":"Timbie","year":"2015","journal-title":"J Control Release."},{"issue":"3","key":"2022061715231922300_B51","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/gt.2009.148","article-title":"Progress and prospects: immune responses to viral vectors","volume":"17","author":"Nayak","year":"2010","journal-title":"Gene Ther."},{"issue":"1","key":"2022061715231922300_B52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1538-7836.2003.00024.x","article-title":"Complete and sustained phenotypic correction of hemophilia B in mice following hepatic gene transfer of a high-expressing human factor IX plasmid","volume":"1","author":"Ye","year":"2003","journal-title":"J Thromb Haemost."},{"issue":"2","key":"2022061715231922300_B53","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jconrel.2011.08.020","article-title":"Ultrasound and microbubble-assisted gene delivery in Achilles tendons: long lasting gene expression and restoration of fibromodulin KO phenotype","volume":"156","author":"Delalande","year":"2011","journal-title":"J Control Release."},{"issue":"3","key":"2022061715231922300_B54","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3390\/genes9030136","article-title":"Translational advances of hydrofection by hydrodynamic injection","volume":"9","author":"Sendra","year":"2018","journal-title":"Genes (Basel)."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/12\/3557\/1902319\/advancesadv2021006016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/12\/3557\/1902319\/advancesadv2021006016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T15:26:07Z","timestamp":1655479567000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/12\/3557\/484959\/Transcutaneous-ultrasound-mediated-gene-delivery"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,6,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021006016","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,17]]}}}